Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro Oncol. 2023. https://doi.org/10.1093/neuonc/noad149.

Article  PubMed  PubMed Central  Google Scholar 

Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol. 2021. https://doi.org/10.1093/neuonc/noab200.

Article  PubMed  PubMed Central  Google Scholar 

Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, et al. A genetic strategy to overcome the senescence of primary meningioma cell cultures. J Neurooncol. 2006;78(2):113–21. https://doi.org/10.1007/s11060-005-9076-y.

Article  CAS  PubMed  Google Scholar 

Puttmann S, Senner V, Braune S, Hillmann B, Exeler R, Rickert CH, et al. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest. 2005;85(9):1163–71. https://doi.org/10.1038/labinvest.3700307.

Article  CAS  PubMed  Google Scholar 

Cargioli TG, Ugur HC, Ramakrishna N, Chan J, Black PM, Carroll RS. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery. 2007;60(4):750–9. https://doi.org/10.1227/01.NEU.0000255397.00410.8F.

Article  PubMed  Google Scholar 

Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, et al. TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst. 2016. https://doi.org/10.1093/jnci/djv377.

Article  PubMed  Google Scholar 

Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer. 2013;20(4):603–10. https://doi.org/10.1530/ERC-13-0210.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allan M, Bjerke M, Edlund H, Nelander S, Westermark B. Origin of the U87MG glioma cell line: good news and bad news. Sci Transl Med. 2016. https://doi.org/10.1126/scitranslmed.aaf6853.

Article  Google Scholar 

Lee WH. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery. 1990;27(3):389–96.

Article  CAS  PubMed  Google Scholar 

THE HUMAN PROTEIN ATLAS. https://www.proteinatlas.org/. https://www.proteinatlas.org/ENSG00000147889-CDKN2A/cell+line and https://www.proteinatlas.org/ENSG00000147883-CDKN2B/cell+line. Accessed 4 Sept 2024.

Merisaari J, Denisova OV, Doroszko M, Le Joncour V, Johansson P, Leenders WPJ, et al. Monotherapy efficacy of blood-brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma. Brain Commun. 2020. https://doi.org/10.1093/braincomms/fcaa002.

Article  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Wesseling PA-O, Brat DA-O, Cree IA, Figarella-Branger D, et al. The WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021. https://doi.org/10.1093/neuonc/noab106.

Article  PubMed  PubMed Central  Google Scholar 

Spiegl-Kreinecker S, Lotsch D, Neumayer K, Kastler L, Gojo J, Pirker C, et al. TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro Oncol. 2018;20(12):1584–93. https://doi.org/10.1093/neuonc/noy104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339(6122):957–9. https://doi.org/10.1126/science.1229259.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013;110(15):6021–6. https://doi.org/10.1073/pnas.1303607110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ragel BT, Couldwell WT, Gillespie DL, Wendland MM, Whang K, Jensen RL. A comparison of the cell lines used in meningioma research. Surg Neurol. 2008;70(3):295–307. https://doi.org/10.1016/j.surneu.2007.06.031.

Article  PubMed  Google Scholar 

Rempel SA, Schwechheimer K, Davis RL, Cavenee WK, Rosenblum ML. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res. 1993;53:2386–92.

CAS  PubMed  Google Scholar 

Akat K, Mennel HD, Kremer P, Gassler N, Bleck CK, Kartenbeck J. Molecular characterization of desmosomes in meningiomas and arachnoidal tissue. Acta Neuropathol. 2003;106(4):337–47. https://doi.org/10.1007/s00401-003-0736-8.

Article  CAS  PubMed  Google Scholar 

Kim E, Kim M, So K, Park YS, Woo CG, Hyun SH. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors. Cancer Cell Int. 2020;20:345. https://doi.org/10.1186/s12935-020-01438-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, et al. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med. 2015;13:227. https://doi.org/10.1186/s12967-015-0596-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, et al. CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol. 2020;140(3):409–13. https://doi.org/10.1007/s00401-020-02188-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C. Why is the partial oxygen pressure of human tissues a crucial parameter? small molecules and hypoxia. J Cell Mol Med. 2011;15(6):1239–53. https://doi.org/10.1111/j.1582-4934.2011.01258.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miiller M, Padberg W, Schindler E, Sticher J, Osmer C, Friemann S, et al. Renocortical tissue oxygen pressure measurements in patients undergoing living donor kidney transplantation. Anesth Analg. 1998;82(8):474–6. https://doi.org/10.1097/00000539-199808000-00045.

Article  Google Scholar 

Beppu T, Kamada K, Yoshida Y, Arai H, Ogasawara K. Chenge of oxygen pressure in GBM tissue under various conditions. J Neurooncol. 2002;58:47–52. https://doi.org/10.1023/a:1015832726054.

Article  PubMed  Google Scholar 

Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol. 2003;5:741–7. https://doi.org/10.1038/ncb1024.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Betts DH, Perrault SD, King WA. Low oxygen delays fibroblast senescence despite shorter telomeres. Biogerontology. 2008;9(1):19–31. https://doi.org/10.1007/s10522-007-9113-7.

Article  CAS  PubMed  Google Scholar 

Poulios E, Trougakos IP, Chondrogianni N, Gonos ES. Exposure of human diploid fibroblasts to hypoxia extends proliferative life span. Ann N Y Acad Sci. 2007;1119:9–19. https://doi.org/10.1196/annals.1404.025.

Article  CAS  PubMed  Google Scholar 

Otero-Albiol D, Carnero A. Cellular senescence or stemness: hypoxia flips the coin. J Exp Clin Cancer Res. 2021;40(1):243. https://doi.org/10.1186/s13046-021-02035-0.

Article  PubMed  PubMed Central